Skip to main content

Table 4 Differences in prescribed drugs for men in different BMI-categories: bivariate and multilevel analyses

From: Moderately overweight and obese patients in general practice: a population based survey

  Bivariate analyses a) Percentage that got prescribed for ICPC-chapter Multilevel logistic regression b,c)
Adjusted odds ratios [95% BI]
ATC-Chapter BMI < 25kg/m2
(n = 1980)
BMI 25- <30 kg/m2
(n = 1707)
BMI = 30 kg/m2
(n = 361)
  BMI 25- <30 kg/m2 BMI ≥ 30 kg/m2
Alimentary tract and metabolism (A) 14.0 16.9 25.2 p < 0.001 1.01 [0.83–1.22] 1.66* [1.24–2.21]
Blood and blood forming organs (B) 9.2 14.2 13.3 p < 0.001 1.29* [1.02–1.63] 1.23 [0.83–1.81]
Cardiovascular system (C) 14.6 25.2 32.1 p < 0.001 1.62* [1.34–1.97] 2.81* [2.09–3.77]
Dermatologicals (D) 18.9 22.1 26.3 p = 0.002 1.12 [0.95–1.32] 1.37* [1.05–1.80]
Genito urinary system and sex homones (G) 3.3 4.5 3.3 ns 1.11 [0.78–1.58] 0.84 [0.43–1.64]
Systemic hormonal preparations (H) 3.7 4.5 8.0 p = 0.001 1.01 [0.73–1.42] 1.79* [1.13–2.85]
Antiinfectives for systemic use (J) 21.6 27.5 32.4 p < 0.001 1.12 [0.95–1.31] 1.36* [1.04–1.77]
Antineoplastic and immunomodulating agents (L) 0.4 0.4 0.6 ns 0.95 [0.33–2.75] 1.20 [0.24–5.98]
Musculoskeletal system (M) 14.3 20.8 30.2 p < 0.001 1.43* [1.20–1.71] 2.18* [1.67–2.85]
Nervous system (N) 14.8 18.2 21.6 p = 0.001 1.12 [0.94–1.35] 1.30 [0.97–1.74]
Antiparasitic products (P) 0.8 0.8 1.7 ns 0.96 [0.45–2.01] 2.16 [0.82–5.64]
Respiratory system (R) 15.8 18.6 23.0 p < 0.001 1.12 [0.94–1.33] 1.40* [1.06–1.85]
Sensory organs (S) 7.9 8.6 9.4 ns 0.98 [0.77–1.25] 1.01 [0.67–1.51]
  1. a) significance test: Pearson Chi-square test, ns= not significant (p < 0.05), ns = not significant (p > 0.05)
  2. b) Multilevel logistic regression, odds ratios are corrected for age, sex, educational level, type of health insurance, residence, smoking, alcohol consumption and exercising
  3. c) reference in multilevel logistic regression is BMI < 25
  4. * p < 0.05